Perrigo Company plc (NYSE:PRGO) Shares Purchased by Keeley Teton Advisors LLC

Keeley Teton Advisors LLC raised its holdings in shares of Perrigo Company plc (NYSE:PRGO) by 64.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 372,328 shares of the company’s stock after buying an additional 145,383 shares during the period. Perrigo comprises 1.1% of Keeley Teton Advisors LLC’s investment portfolio, making the stock its 6th largest position. Keeley Teton Advisors LLC’s holdings in Perrigo were worth $9,573,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. Jump Financial LLC grew its stake in shares of Perrigo by 8.7% in the fourth quarter. Jump Financial LLC now owns 58,865 shares of the company’s stock valued at $1,513,000 after buying an additional 4,733 shares in the last quarter. Guggenheim Capital LLC lifted its holdings in Perrigo by 50.2% in the 4th quarter. Guggenheim Capital LLC now owns 46,844 shares of the company’s stock worth $1,204,000 after buying an additional 15,648 shares in the last quarter. Mariner LLC purchased a new position in Perrigo in the 4th quarter valued at about $215,000. Barclays PLC grew its stake in shares of Perrigo by 90.0% during the fourth quarter. Barclays PLC now owns 228,908 shares of the company’s stock valued at $5,886,000 after acquiring an additional 108,406 shares in the last quarter. Finally, Hudson Portfolio Management LLC increased its position in shares of Perrigo by 39.6% during the fourth quarter. Hudson Portfolio Management LLC now owns 40,264 shares of the company’s stock worth $1,035,000 after acquiring an additional 11,424 shares during the last quarter. Institutional investors and hedge funds own 95.91% of the company’s stock.

Insider Activity

In other news, EVP Ronald Craig Janish sold 7,800 shares of the company’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares in the company, valued at approximately $923,795.04. This represents a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.70% of the company’s stock.

Perrigo Trading Up 1.3 %

Shares of NYSE PRGO opened at $24.97 on Tuesday. The stock has a market capitalization of $3.41 billion, a P/E ratio of -21.34 and a beta of 0.49. The stock’s 50 day moving average price is $26.43 and its two-hundred day moving average price is $26.06. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. Perrigo Company plc has a 52-week low of $23.14 and a 52-week high of $33.46.

Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.92 by $0.01. The firm had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.20 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. On average, analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th were paid a $0.29 dividend. This is an increase from Perrigo’s previous quarterly dividend of $0.28. This represents a $1.16 dividend on an annualized basis and a yield of 4.65%. The ex-dividend date of this dividend was Friday, March 7th. Perrigo’s payout ratio is presently -92.80%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on PRGO shares. Argus lowered Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. StockNews.com downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 19th. Finally, Piper Sandler cut shares of Perrigo from an “overweight” rating to a “neutral” rating and cut their price target for the company from $34.00 to $27.00 in a report on Monday, January 6th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $33.00.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.